Skip to main content
. 2019 May 16;11(5):e4679. doi: 10.7759/cureus.4679

Figure 5. Risk evaluation and management of TLS.

Figure 5

TLS: Tumor Lysis Syndrome; ULN: Upper Limit of Normal; LDH: Lactate Dehydrogenase; IV: Intravenous; PO: Per Oral.